Burney Co. Has $2.88 Million Stock Holdings in Waters Co. (NYSE:WAT)

Burney Co. reduced its stake in shares of Waters Co. (NYSE:WATFree Report) by 13.0% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 10,799 shares of the medical instruments supplier’s stock after selling 1,616 shares during the period. Burney Co.’s holdings in Waters were worth $2,878,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of WAT. Glassman Wealth Services boosted its stake in shares of Waters by 39.6% during the 2nd quarter. Glassman Wealth Services now owns 141 shares of the medical instruments supplier’s stock worth $38,000 after buying an additional 40 shares during the last quarter. CWM LLC raised its stake in Waters by 12.4% in the first quarter. CWM LLC now owns 372 shares of the medical instruments supplier’s stock valued at $115,000 after buying an additional 41 shares during the period. Wetherby Asset Management Inc. lifted its position in shares of Waters by 2.9% in the first quarter. Wetherby Asset Management Inc. now owns 1,645 shares of the medical instruments supplier’s stock valued at $511,000 after buying an additional 46 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in shares of Waters by 1.0% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,888 shares of the medical instruments supplier’s stock worth $1,513,000 after acquiring an additional 50 shares during the last quarter. Finally, Orion Portfolio Solutions LLC raised its stake in Waters by 4.8% in the 1st quarter. Orion Portfolio Solutions LLC now owns 1,100 shares of the medical instruments supplier’s stock valued at $341,000 after acquiring an additional 50 shares during the period. Institutional investors own 94.01% of the company’s stock.

Waters Price Performance

Shares of WAT stock opened at $267.05 on Thursday. The business has a fifty day simple moving average of $260.31 and a 200 day simple moving average of $268.48. Waters Co. has a twelve month low of $231.90 and a twelve month high of $353.70. The company has a quick ratio of 1.46, a current ratio of 2.19 and a debt-to-equity ratio of 2.71. The company has a market cap of $15.79 billion, a P/E ratio of 24.26, a P/E/G ratio of 5.50 and a beta of 0.90.

Waters (NYSE:WATGet Free Report) last issued its quarterly earnings results on Tuesday, November 7th. The medical instruments supplier reported $2.84 EPS for the quarter, topping analysts’ consensus estimates of $2.56 by $0.28. The company had revenue of $711.69 million for the quarter, compared to analyst estimates of $722.27 million. Waters had a net margin of 21.80% and a return on equity of 102.22%. Waters’s revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.64 earnings per share. On average, sell-side analysts forecast that Waters Co. will post 11.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have commented on WAT. StockNews.com began coverage on shares of Waters in a report on Thursday, October 5th. They issued a “hold” rating on the stock. Sanford C. Bernstein started coverage on shares of Waters in a research note on Thursday, September 28th. They issued a “market perform” rating and a $280.00 price target on the stock. JPMorgan Chase & Co. cut their price objective on shares of Waters from $260.00 to $250.00 and set a “neutral” rating for the company in a research report on Wednesday, November 8th. Stifel Nicolaus decreased their target price on Waters from $305.00 to $290.00 and set a “hold” rating on the stock in a research report on Wednesday, November 8th. Finally, TheStreet cut Waters from a “b-” rating to a “c+” rating in a report on Wednesday, October 18th. One analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $298.00.

Read Our Latest Report on WAT

Waters Profile

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.